HI
PACB icon

Harbour Investments’s Pacific Biosciences PACB Stock Holding History

Harbour Investments’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306 Buy
182
+44
+32% +$64 ﹤0.01% 4469
2026
Q1 		$183 Buy
+138
New +$247 ﹤0.01% 4450
2021
Q4 		– Sell
-37
Closed -$1K – 3383
2021
Q3 		$1K Hold
37
– – ﹤0.01% 3572
2021
Q2 		$1K Buy
37
+23
+164% +$669 ﹤0.01% 3620
2021
Q1 		$0 Buy
+14
New +$490 ﹤0.01% 3689

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Harbour Investments's PACB Position: Q2 2026 in Review

Harbour Investments increased its Pacific Biosciences (PACB) stake by 32% in Q2 2026, buying an estimated $64 and bringing the position to 182 shares worth $306. The position accounts for ﹤0.01% of the portfolio, ranked #4469.

Harbour Investments first reported a position in PACB in Q1 2021 and has held it in 5 quarters since. The position peaked at $1K in Q3 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Harbour Investments held 182 shares of Pacific Biosciences worth $306 as of Q2 2026.
  • Harbour Investments bought 44 Pacific Biosciences shares in Q2 2026, an estimated $64.
  • Pacific Biosciences made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4469 holding.
  • Harbour Investments first reported a position in Pacific Biosciences in Q1 2021 and has held it in 5 quarters since.
  • Harbour Investments's Pacific Biosciences position peaked at $1K in Q3 2021.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.